Increased interleukin 10, tumor necrosis factor α, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis

Journal of the American Academy of Dermatology

Volumn 47, Issue 1, 2002, Pages 58-62

  Correia, Osvaldo ^a,b   Delgado, Luís ^b   Barbosa, Isabel Leal ^a   Campilho, Fernando ^a   Fleming Torrinha, José ^b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLISTER; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; EPIDERMOLYSIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036657502     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120473     Document Type: Article

References (37)

1. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990;23:1039-58.
2. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern R, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
3. Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology 1993;186:32-7.
4. Villada G, Roujeau JC, Cordonnier C, Bagot M, Kuentz M, Wechsler J, et al. Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol 1990;23: 870-5.
5. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive T cells. Arch Dermatol 1991;127:851-5.
6. Correia O, Delgado L, Ramos JP, Resende C, Fleming-Torrinha JA. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. Arch Dermatol 1993;129:466-8.
7. Cleach LE, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer(NK) inhibitory receptors. Clin Exp Immunol 2000;119:225-30.
8. Wehrli P, Viard I, Bullani R,Tschoop J, French LE. Death receptors in cutaneous biology and disease. J Invest Dermatol 2000;115: 141-8.
9. French LE, Tschopp J. Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition. Schweiz Med Wochenschr 2000;130:1656-61.
10. Arnold R, Seifert M, Asadullah K, Volk HD. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 1999;162:7140-7.
11. Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996;183:2645-56.
12. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996;183:657-61.
13. Kayaba H, Hirokawa M, Watanabe A, Saitoh N, Changha C, Yamada Y, et al. Serum markers of graft-versus-host disease after bone marrow transplantation. J Allergy Clin Immunol 2000; 106(Suppl):S40-4.
14. Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, et al. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 1990;75:1011-6.
15. Steffen M, Pichlmeier U, Zander A. Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells. Bone Marrow Transplant 1997;20:715-20.
16. Paquet P, Pierard GE. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns. Int J Mol Med 1998;1:459-62.
17. Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, et al. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. Bone Marrow Transplant 1999;24:1005-7.
18. Spits H, Malefyt RW. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992;99:8-15.
19. Moore KW, O'Garra A, Malefyt RW, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
20. Bastuji-Garin S, Rzany B, Stern R, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson and erythema multiforme. Arch Dermatol 1993;129:92-6.
21. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismaire F, et al. Adverse drug reaction monitoring: doing it in the French way. Lancet 1985;2:1056-8.
22. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998;134:602-12.
23. Johnson LCML, Farmer ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998;38:369-92.
24. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J et, al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-4.
25. Langley R, Walsch N, Nevill T, Thomas L, Rowden G. Apoptosis is the mode of keratinocyte death in cutaneous graft versus host disease. J Am Acad Dermatol 1996;35:187-90.
26. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN. Circulating interleukin-6 mediates the febrile response to localized inflammation in rats. J Physiol 2000;526:653-61.
27. Leon LR, Kozak W, Rudolph K, Kluger MJ. An antipyretic role for interleukin-10 in LPS fever in mice. Am J Physiol 1999;276:R81-9.
28. Enk AH, Katz S. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992;149:92-5.
29. Rhodes LE, Hashim IA, McLaughlin PJ, Friedmann PS. Blister fluid cytokines in cutaneous inflammatory bullous disorders. Acta Derm Venereol 1999;79:288-90.
30. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998;352:1586-9.
31. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-54.
32. Wakefield PE, James WD, Samlaska CP, Meltzer MS. Tumor necrosis factor. J Am Acad Dermatol 1991;24:675-85.
33. Symington FW. Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes. J Invest Dermatol 1989;92:798-805.
34. Giacalone B, D'Auria L, Ferraro C, Mussi A, Bonifati C, Ameglio F. Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters. Br J Dermatol 1998;139:158-9.
35. Zillikens D, Schuessler M, Dummer R, Porzsolt F, Hartmann AA, Burg G. Tumor necrosis factor in blister fluids of bullous pemphigoid. Eur J Dermatol 1992;2:429-31.
36. Schmidt E, Bastian B, Dummer R, Tony HS, Bröcker EB, Zillikens D. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 1996; 288:353-7.
37. Bhol KC, Rojas Al, Khan IU, Ahmed AR. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine 2000;12:1076-83.